Search results for "From ACP Internist"


 
Results 41 - 50 of about 78 for "From ACP Internist".

GLP-1 analogues may be associated with bile duct, gallbladder disease | ACP Diabetes Monthly

Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral antidiabetic drugs, but an increased risk was seen with use of GLP-1 analogues.

Physician volume linked to diabetes care quality, study finds | ACP Diabetes Monthly

The researchers found that higher ambulatory volume overall was associated with lower rates of appropriate eye exams, HbA1c testing, and LDL cholesterol testing, but higher diabetes-specific volume was associated with better care according to

Task Force releases systematic review about diabetes screening | ACP Diabetes Monthly

A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.

October 7, 2016 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

June 12, 2015 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis | ACP Diabetes Monthly

Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a

June 8, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

September 8, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Physicians may overtreat blood pressure, glucose in older patients with diabetes | ACP Diabetes Monthly

A retrospective cohort study used data from the Department of Veterans Affairs to assess both hypertension and blood glucose medication deintensification (i.e., dosage reduction or withdrawal of a drug).

February 10, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   1   2   3   4   5   6   7   8   Next